Literature DB >> 3891756

Specificity of binding of a strain of uropathogenic Escherichia coli to Gal alpha 1----4Gal-containing glycosphingolipids.

K Bock, M E Breimer, A Brignole, G C Hansson, K A Karlsson, G Larson, H Leffler, B E Samuelsson, N Strömberg, C S Edén.   

Abstract

A strain of Escherichia coli originally isolated from urine of a patient with acute pyelonephritis was studied in detail for binding to glycosphingolipids. Bacteria labeled metabolically with [14C]glucose were layered over a glycolipid chromatogram and bound bacteria were detected by autoradiography. The detection was down to a few ng of glycolipid (pmol level) under these assay conditions. At a test level of 500 ng all glycolipids (more than a dozen molecular species analyzed) with Gal alpha 1----4Gal as an internal or terminal part bound the bacteria strongly while glycolipids known to lack this sequence were negative. Conformational analysis using hard sphere calculations including the exo-anomeric effect showed a bend in the saccharide chain at this disaccharide with a largely hydrophobic surface of the convex side, probably being part of the binding epitope. Mixtures of glycolipids isolated from a human ureter scraping and from urinary sediments bound bacteria in the 2- to 7-sugar interval. Thus, this infectious strain of E. coli recognizes glycolipids being present in epithelial cells lining the urinary tract.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3891756

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Cpx signaling pathway monitors biogenesis and affects assembly and expression of P pili.

Authors:  D L Hung; T L Raivio; C H Jones; T J Silhavy; S J Hultgren
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Chaperone-subunit-usher interactions required for donor strand exchange during bacterial pilus assembly.

Authors:  Michelle M Barnhart; Frederic G Sauer; Jerome S Pinkner; Scott J Hultgren
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

3.  Bacterial outer membrane ushers contain distinct targeting and assembly domains for pilus biogenesis.

Authors:  David G Thanassi; Christos Stathopoulos; Karen Dodson; Dominik Geiger; Scott J Hultgren
Journal:  J Bacteriol       Date:  2002-11       Impact factor: 3.490

4.  P pilus assembly motif necessary for activation of the CpxRA pathway by PapE in Escherichia coli.

Authors:  Yvonne M Lee; Patricia A DiGiuseppe; Thomas J Silhavy; Scott J Hultgren
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

5.  The usher N terminus is the initial targeting site for chaperone-subunit complexes and participates in subsequent pilus biogenesis events.

Authors:  Tony W Ng; Leyla Akman; Mary Osisami; David G Thanassi
Journal:  J Bacteriol       Date:  2004-08       Impact factor: 3.490

Review 6.  Surface organelles assembled by secretion systems of Gram-negative bacteria: diversity in structure and function.

Authors:  David G Thanassi; James B Bliska; Peter J Christie
Journal:  FEMS Microbiol Rev       Date:  2012-05-24       Impact factor: 16.408

Review 7.  Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria.

Authors:  Peter Chahales; David G Thanassi
Journal:  Microbiol Spectr       Date:  2015-10

8.  Shiga toxin binds human platelets via globotriaosylceramide (Pk antigen) and a novel platelet glycosphingolipid.

Authors:  L L Cooling; K E Walker; T Gille; T A Koerner
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Different glycosphingolipid composition in human neutrophil subcellular compartments.

Authors:  A Karlsson; H Miller-Podraza; P Johansson; K A Karlsson; C Dahlgren; S Teneberg
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

10.  Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli.

Authors:  J R Johnson; K M Skubitz; B J Nowicki; K Jacques-Palaz; R M Rakita
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.